Kim Pacchiardi

Paris, 75010, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

Journal: Science translational medicine

Published: July 08, 2026

Prospective feasibility of a minimal BH3 profiling assay in acute myeloid leukemia.

Prospective feasibility of a minimal BH3 profiling assay in acute myeloid leukemia.

Journal: Cytometry. Part B, Clinical cytometry

Published: March 12, 2024

Drug combinations screening using a Bayesian ranking approach based on dose-response models.

Drug combinations screening using a Bayesian ranking approach based on dose-response models.

Journal: Biometrical journal. Biometrische Zeitschrift

Published: November 30, 2022

Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML.

Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML.

Journal: Blood cancer journal

Published: August 12, 2022

Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively.

Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively.

Journal: HemaSphere

Published: July 15, 2022

Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation.

Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation.

Journal: Blood

Published: May 04, 2022

A multiparametric niche-like drug screening platform in acute myeloid leukemia.

A multiparametric niche-like drug screening platform in acute myeloid leukemia.

Journal: Blood cancer journal

Published: November 30, 2021

Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.

Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.

Journal: Leukemia

Published: October 12, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026